Dressed Up Diagnostics?
Executive SummaryNanogen's positioning of its in-development molecular biology workstation as a genomics tool as well as an IVD instrument helped it raise $82.5 million in a FOPO--an extraordinary amount for a company long-considered a diagnostics instrument maker. In that way, it 'caught the wave' of the excitement over genomics that hit the stock market in early 2000.
You may also be interested in...
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.